Evidence map›Paper›PMID 32377072›Full record

ArticleSisli Etfal Hastanesi tip bulteni2019

The Effect of Single High-Dose Preoperative Intravenous Tranexamic Acid Administration to Reduce Blood Loss in Patients with Primary Total Knee Replacement.

Mehmet Ali Talmaç, Mehmet Akif Görgel, Sema Ertan Birsel, Mehmet Mesut Sönmez, Hacı Mustafa Özdemir

Open access · hybridAbstract read
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mehmet Ali TalmaçDepartment of Orthopaedics, Health Sciences University Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Mehmet Akif GörgelDepartment of Orthopaedics, Health Sciences University Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Sema Ertan BirselDepartment of Orthopaedics, Istanbul Private Medicine Hospital, Istanbul, Turkey.
Mehmet Mesut SönmezDepartment of Orthopaedics, Health Sciences University Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Hacı Mustafa ÖzdemirDepartment of Orthopaedics, Health Sciences University Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Sağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to analyze the efficacy of single-dose tranexamic acid (TA) 20 mg/kg preoperatively to reduce blood loss in patients undergoing total knee replacement (TKR).

methodsA total of 387 patients (82 males, 305 females) undergoing TKR between January 2014 and December 2018 were included in the study. The T + group was administrated intravenous (iv) TA 20 mg/kg 20 min before the skin incision. We determined perioperative blood loss, the amount of drainage postoperative 24 h, the amount of drainage after postoperative 24-48 h, total volume of drains, total volume of blood loss, postoperative hemoglobin and hematocrit levels, and amount of total blood transfusion.

resultsIn terms of demographic data, no statistically significant difference was observed between the groups. Perioperative blood loss and total volume of blood loss was found statistically higher in T - group compared to T + group. Postoperatively, the mean hemoglobin and hematocrit levels of T - group were statistically significantly lower than T + group.

conclusionA single 20 mg/kg iv TA administration before TKR reduces bleeding during surgery and within 24 h postoperatively.

Indexed as

Blood lossdeep vein thrombosisknee replacementtranexamic acid

Identifiers

PMID32377072
PMCPMC7199840
OpenAlexW2895713455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.